Markets.com Logo

MBINO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    --$
  • Previous Close
    --$
  • 52 Week Change
    --
  • Day Range
    --
  • 52 Week High/Low
    --
  • Dividend Per Share
    --
  • Market cap
    --$
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

MBINO.US represents Microbot Medical Inc., a company focused on designing, developing, and commercializing micro-robotic endovascular technologies for neurovascular and peripheral vascular applications. Their core technology aims to improve precision and safety during surgical procedures by allowing physicians to remotely navigate microcatheters and guidewires through intricate vasculature. The company's products are still under development and regulatory approval, making it a speculative investment centered on the potential success of their robotic surgical platform.

Gold Volatility: Is a Structural Shift Underway? An In-depth Analysis

Noah Lee|--

S&P 500's Record Rally Continues: Nomura Strategist Flags Two Key Exit Signals

Liam James|--

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist

Emma Rose|--

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Factors

Company Performance: MBINO's revenue, earnings, and growth prospects significantly impact its stock price.

Industry Trends: Overall health and growth of the biotechnology industry affects investor sentiment towards MBINO.

Clinical Trial Results: Positive or negative outcomes from clinical trials directly influence investor confidence.

Regulatory Approvals: FDA approvals of MBINO's products lead to increased revenue potential and stock price appreciation.

Market Conditions: General economic conditions, interest rates, and investor risk appetite play a role.

Competition: The presence of competing drugs or technologies impacts MBINO's market share and profitability.

News and Events: Company-specific announcements, acquisitions, partnerships, and major news events can cause volatility.

Investor Sentiment: Public perception of MBINO and its management team affects stock demand and valuation.

People Also Watch

Latest news

Japan's Central Bank Poised for Rate Hike Amidst Heightened Middle East Tensions

Ava Grace|--

US Stocks Hit Record Highs as Geopolitical Fears Ease, Tech Bet Surge

Ava Grace|--

Fed Chair Succession Sparks Legal Battle Over Independence

Noah Lee|--

Latest Education Articles

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Crypto Trends in 2026: 7 Key Developments Every Investor Should Watch

Julian Parker|--
Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Frances Wang|--
Recommended Topics